Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ALX Oncology Inc.
City of Hope Medical Center
Seagen Inc.
Novartis
Eli Lilly and Company
Compugen Ltd
Columbia University
HiberCell, Inc.
Genzada Pharmaceuticals USA, Inc.
MacroGenics
MacroGenics
University of Wisconsin, Madison
Synermore Biologics Co., Ltd.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Duke University
Calando Pharmaceuticals
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
Pharmacyclics LLC.